An international forum dedicated to Paul Ehrlich, the founder of chemotherapy
Aims and Scope
This journal publishes original research articles and state-of-the-art reviews on all aspects of antiinfective and antitumor chemotherapy. The results of experimental and clinical investigations into the microbiological and pharmacologic properties of antibacterial, antiviral and antitumor compounds are major topics of publication. Papers selected for the journal offer data concerning the efficacy, toxicology, and interactions of new drugs in single or combined applications. Studies designed to determine the pharmacokinetic and pharmacodynamic properties of similar preparations and comparing their efficacy are also included. Special emphasis is given to the development of drug-resistance, an increasing problem worldwide. Regular supplement issues devoted to specific topics related to antibiotic and cytostatic chemotherapy provide an additional bonus for subscribers.
Published online first
All articles are published electronically ahead of print with the definite citation line. Thus, an article will be available online shortly after the author's approval to print.
Bibliographic Details
Chemotherapy
International Journal of Experimental and Clinical Chemotherapy
Journal Abbreviation: Chemotherapy
www.karger.com/CHE
ISSN 0009-3157 (Print)
e-ISSN 1421-9794 (Online)
Indexing/Abstracting
Listed in bibliographical services, including Current Contents/Life Sciences, MEDLINE, Excerpta Medica, Biological Abstracts, Chemical Abstracts.
History
Founded 1959 as ‘Chemotherapia’
Continued by H. Schönfeld (1968–2001)
Formerly: Chemotherapia
|
|
 |
| Search in this journal
|
|
|
|
For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service. |
|
|
Journal Home
Aims and Scope
